Identifying high-risk patients with interstitial lung abnormalities
Risk-stratification and prediction of adverse outcomes in interstitial lung abnormalities
['FUNDING_CAREER'] · BRIGHAM AND WOMEN'S HOSPITAL · NIH-11057656
This study is looking at lung issues that could lead to serious problems like pulmonary fibrosis, and it's for people with these lung abnormalities; the goal is to find out who might be at greater risk so that doctors can step in early and help improve their treatment.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BRIGHAM AND WOMEN'S HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11057656 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding interstitial lung abnormalities (ILA) that can lead to pulmonary fibrosis, a serious lung condition. The team aims to develop methods to predict which patients with ILA are at higher risk for adverse outcomes, using advanced imaging techniques and clinical data. By identifying these high-risk patients, the research seeks to facilitate early intervention and improve treatment outcomes. The study will also explore novel biomarkers to enhance risk stratification and better understand the disease mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with interstitial lung abnormalities who may be at risk for developing pulmonary fibrosis.
Not a fit: Patients with established pulmonary fibrosis or those without interstitial lung abnormalities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment options for patients at risk of developing pulmonary fibrosis.
How similar studies have performed: Previous research has shown promise in using imaging and clinical data to predict outcomes in similar patient populations, indicating a potential for success in this approach.
Where this research is happening
BOSTON, UNITED STATES
- BRIGHAM AND WOMEN'S HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROSE, JONATHAN — BRIGHAM AND WOMEN'S HOSPITAL
- Study coordinator: ROSE, JONATHAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.